InvestorsHub Logo

Buyfor1sell for2

06/15/20 9:03 AM

#141991 RE: Buyfor1sell for2 #141990

ADMP Adamis Pharmaceuticals Announces License to Commercialize Tempol, a Novel Investigational Anti-inflammatory and Antioxidant Drug for the Treatment of Respiratory Diseases Including COVID-19